Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer

<h4>Background</h4> Androgen receptor (AR) is a potential therapeutic target in triple-negative breast cancer (TNBC). We aimed to elucidate the association of AR expression with glucose metabolic features in TNBC. <h4>Methods</h4> Two independent datasets were analyzed: FDG P...

Full description

Bibliographic Details
Main Authors: Reeree Lee, Han-Byoel Lee, Jin Chul Paeng, Hongyoon Choi, Wonseok Whi, Wonshik Han, Ju Won Seok, Keon Wook Kang, Gi Jeong Cheon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524647/?tool=EBI
_version_ 1811229937659543552
author Reeree Lee
Han-Byoel Lee
Jin Chul Paeng
Hongyoon Choi
Wonseok Whi
Wonshik Han
Ju Won Seok
Keon Wook Kang
Gi Jeong Cheon
author_facet Reeree Lee
Han-Byoel Lee
Jin Chul Paeng
Hongyoon Choi
Wonseok Whi
Wonshik Han
Ju Won Seok
Keon Wook Kang
Gi Jeong Cheon
author_sort Reeree Lee
collection DOAJ
description <h4>Background</h4> Androgen receptor (AR) is a potential therapeutic target in triple-negative breast cancer (TNBC). We aimed to elucidate the association of AR expression with glucose metabolic features in TNBC. <h4>Methods</h4> Two independent datasets were analyzed: FDG PET data of our institution and a public dataset of GSE135565. In PET analysis, patients with TNBC who underwent pretreatment PET between Jan 2013 and Dec 2017 were retrospectively enrolled. Clinicopathologic features and maximum standardized uptake value (SUVmax) of tumors were compared with AR expression. In GSE135565 dataset, glycolysis score was calculated by the pattern of glycolysis-related genes, and of which association with SUVmax and AR gene expression were analyzed. <h4>Results</h4> A total of 608 female patients were included in the PET data of our institution. SUVmax was lower in AR-positive tumors (P < 0.001) and correlated with lower AR expression (rho = –0.26, P < 0.001). In multivariate analysis, AR was a deterministic factor for low SUVmax (P = 0.012), along with other key clinicopathologic features. In the GSE135565 dataset, AR expression also exhibited a negative correlation with SUVmax (r = –0.34, P = 0.001) and the glycolysis score (r = –0.27, P = 0.013). <h4>Conclusions</h4> Low glucose metabolism is a signature of AR expression in TNBC. It is suggested that evaluation of AR expression status needs to be considered in clinical practice particularly in TNBC with low glucose metabolism.
first_indexed 2024-04-12T10:21:33Z
format Article
id doaj.art-7e561aa21fe34636a400b40c718adb0c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T10:21:33Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7e561aa21fe34636a400b40c718adb0c2022-12-22T03:37:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01179Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancerReeree LeeHan-Byoel LeeJin Chul PaengHongyoon ChoiWonseok WhiWonshik HanJu Won SeokKeon Wook KangGi Jeong Cheon<h4>Background</h4> Androgen receptor (AR) is a potential therapeutic target in triple-negative breast cancer (TNBC). We aimed to elucidate the association of AR expression with glucose metabolic features in TNBC. <h4>Methods</h4> Two independent datasets were analyzed: FDG PET data of our institution and a public dataset of GSE135565. In PET analysis, patients with TNBC who underwent pretreatment PET between Jan 2013 and Dec 2017 were retrospectively enrolled. Clinicopathologic features and maximum standardized uptake value (SUVmax) of tumors were compared with AR expression. In GSE135565 dataset, glycolysis score was calculated by the pattern of glycolysis-related genes, and of which association with SUVmax and AR gene expression were analyzed. <h4>Results</h4> A total of 608 female patients were included in the PET data of our institution. SUVmax was lower in AR-positive tumors (P < 0.001) and correlated with lower AR expression (rho = –0.26, P < 0.001). In multivariate analysis, AR was a deterministic factor for low SUVmax (P = 0.012), along with other key clinicopathologic features. In the GSE135565 dataset, AR expression also exhibited a negative correlation with SUVmax (r = –0.34, P = 0.001) and the glycolysis score (r = –0.27, P = 0.013). <h4>Conclusions</h4> Low glucose metabolism is a signature of AR expression in TNBC. It is suggested that evaluation of AR expression status needs to be considered in clinical practice particularly in TNBC with low glucose metabolism.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524647/?tool=EBI
spellingShingle Reeree Lee
Han-Byoel Lee
Jin Chul Paeng
Hongyoon Choi
Wonseok Whi
Wonshik Han
Ju Won Seok
Keon Wook Kang
Gi Jeong Cheon
Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
PLoS ONE
title Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
title_full Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
title_fullStr Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
title_full_unstemmed Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
title_short Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
title_sort association of androgen receptor expression with glucose metabolic features in triple negative breast cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524647/?tool=EBI
work_keys_str_mv AT reereelee associationofandrogenreceptorexpressionwithglucosemetabolicfeaturesintriplenegativebreastcancer
AT hanbyoellee associationofandrogenreceptorexpressionwithglucosemetabolicfeaturesintriplenegativebreastcancer
AT jinchulpaeng associationofandrogenreceptorexpressionwithglucosemetabolicfeaturesintriplenegativebreastcancer
AT hongyoonchoi associationofandrogenreceptorexpressionwithglucosemetabolicfeaturesintriplenegativebreastcancer
AT wonseokwhi associationofandrogenreceptorexpressionwithglucosemetabolicfeaturesintriplenegativebreastcancer
AT wonshikhan associationofandrogenreceptorexpressionwithglucosemetabolicfeaturesintriplenegativebreastcancer
AT juwonseok associationofandrogenreceptorexpressionwithglucosemetabolicfeaturesintriplenegativebreastcancer
AT keonwookkang associationofandrogenreceptorexpressionwithglucosemetabolicfeaturesintriplenegativebreastcancer
AT gijeongcheon associationofandrogenreceptorexpressionwithglucosemetabolicfeaturesintriplenegativebreastcancer